Avery Dennison Specialty Tape's ultra-thin hydrocolloid adhesives deliver real consumer benefits

Dec 22 2009

Avery Dennison Specialty Tape has developed a proprietary adhesive technology that adds significant value to consumer wound care products. Its newest generation of ultra-thin hydrocolloid adhesives delivers real consumer benefits in terms of better wear comfort, flexibility, longer wear time, less skin softening beneath the dressing, and gentle removal.

High-performance OTC wound care products

Much thinner than conventional hydrocolloids, the new Avery Dennison products - available worldwide - surpass the fluid-handling performance of thicker hydrocolloid formulations. They reduce the risk of skin irritation and - partnered by a choice of highly-breathable and conformable film carriers - offer a real advance in the technology available for consumer wound and skin care products for over-the-counter sale. A special hydrocolloid formulation with a moisturizing capability is offered for dry and cracked skin and treatment of callouses and corns, especially on feet.

Choice of manufacturing options

Avery Dennison Specialty Tape division is ready to partner brand owners and private label companies in introducing the benefits of this new technology to their consumer customers. Options include the supply of rolls of a thin hydrocolloid laminate for subsequent slitting/cutting to singles; converted product for packaging by the brand owner; or fully-packaged consumer products ready for the retail shelf.

Comments Gert Van Der Haegen, market manager, medical, Europe: "This innovative thin hydrocolloid technology really offers the possibility to create a range of very novel consumer product designs, bringing real benefits for consumers. In the process, it will also enhance the brand owner's image and market positioning."

The future: professional and surgical use

Following its successful introduction for consumer wound care, the new Avery Specialty Tape thin hydrocolloid technology is now also in the stability and safety testing phase for a number of potential professional wound care, stoma care, and surgical applications.